Invesco Ltd. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$303,895
-17.2%
11,293
-7.4%
0.00%
Q2 2023$367,101
-30.3%
12,192
-25.1%
0.00%
Q1 2023$526,626
+7.0%
16,279
-5.2%
0.00%
Q4 2022$492,035
+18.3%
17,168
-0.4%
0.00%
Q3 2022$416,000
-1.2%
17,240
+12.2%
0.00%
Q2 2022$421,000
-9.1%
15,369
+27.4%
0.00%
Q1 2022$463,00012,0620.00%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders